EP3445428B1 - Spacer device for an inhaler - Google Patents

Spacer device for an inhaler Download PDF

Info

Publication number
EP3445428B1
EP3445428B1 EP17785159.9A EP17785159A EP3445428B1 EP 3445428 B1 EP3445428 B1 EP 3445428B1 EP 17785159 A EP17785159 A EP 17785159A EP 3445428 B1 EP3445428 B1 EP 3445428B1
Authority
EP
European Patent Office
Prior art keywords
bag
inlet
outlet
spacer device
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP17785159.9A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP3445428A1 (en
EP3445428A4 (en
Inventor
Barry Spencer CLEMENTS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inspiring Pty Ltd
Original Assignee
Inspiring Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2016901448A external-priority patent/AU2016901448A0/en
Application filed by Inspiring Pty Ltd filed Critical Inspiring Pty Ltd
Priority to PL17785159T priority Critical patent/PL3445428T3/pl
Publication of EP3445428A1 publication Critical patent/EP3445428A1/en
Publication of EP3445428A4 publication Critical patent/EP3445428A4/en
Application granted granted Critical
Publication of EP3445428B1 publication Critical patent/EP3445428B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0086Inhalation chambers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0021Mouthpieces therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0086Inhalation chambers
    • A61M15/0088Inhalation chambers with variable volume
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/009Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/02General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0216Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/02General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0233Conductive materials, e.g. antistatic coatings for spark prevention
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/59Aesthetic features, e.g. distraction means to prevent fears of child patients

Definitions

  • a typical pressurised aerosol container is a metered-dose inhaler (MDI), more commonly referred to as a puffer or as an asthma inhaler, in which the drug is typically provided in solution or suspension within the pressurised container or canister housed in a manual actuator.
  • MDI metered-dose inhaler
  • the mouthpiece of the MDI is placed in the patient's mouth following which the MDI is actuated to express a metered dose of the drug to be breathed in by the patient.
  • valveless spacer device for an MDI, the spacer device comprising:
  • the body including the inlet and outlet, may be configured to reduce a static electricity charge.
  • the bag may be configured to reduce a static electricity charge.
  • the body (including inlet and outlet), and/or bag may be treated with an antistatic agent.
  • the body (including inlet and outlet), and/or bag may be made of electrically conductive material.
  • the body, including the inlet and/or outlet may be made of metal or a metallised compound, such as metallised plastic or a metal-coated plastic.
  • the bag may be made of a metallised film or aluminium foil.
  • the metallised film may be a metallised polymer film.
  • the body is external tc the bag.
  • the bag may depend operatively downwardly from the body.
  • the body is in the form of a generally V-shaped mounting.
  • the V-shaped mounting may be formed by the opposing inlet passage and the outlet passage intersecting at an angle along their respective longitudinal axes where the angle creating the V defines an arc of preferably between 30 and 170 degrees, preferably 60 to 120 degrees, most preferably 90 degrees.
  • the inlet and outlet passages may be cone-shaped.
  • the perimeter of the inlet may be round, oval, elliptical, or irregular in shape.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
EP17785159.9A 2016-04-18 2017-04-18 Spacer device for an inhaler Active EP3445428B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL17785159T PL3445428T3 (pl) 2016-04-18 2017-04-18 Urządzenie dystansowe do inhalatora

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2016901448A AU2016901448A0 (en) 2016-04-18 Inhaler Device
PCT/AU2017/050347 WO2017181228A1 (en) 2016-04-18 2017-04-18 Spacer device for an inhaler

Publications (3)

Publication Number Publication Date
EP3445428A1 EP3445428A1 (en) 2019-02-27
EP3445428A4 EP3445428A4 (en) 2019-12-18
EP3445428B1 true EP3445428B1 (en) 2021-05-19

Family

ID=60115444

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17785159.9A Active EP3445428B1 (en) 2016-04-18 2017-04-18 Spacer device for an inhaler

Country Status (12)

Country Link
US (1) US11207476B2 (pl)
EP (1) EP3445428B1 (pl)
JP (1) JP6979057B2 (pl)
CN (1) CN109310834B (pl)
AU (1) AU2017253951B2 (pl)
CA (1) CA3021217A1 (pl)
DK (1) DK3445428T3 (pl)
ES (1) ES2884121T3 (pl)
MX (1) MX2018012581A (pl)
PL (1) PL3445428T3 (pl)
PT (1) PT3445428T (pl)
WO (1) WO2017181228A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110730674B (zh) * 2017-04-18 2022-02-01 励志私人有限公司 干粉吸入器和用于干粉吸入器的间隔装置
CN110831647B (zh) * 2017-04-18 2022-02-01 励志私人有限公司 用于雾化器的间隔装置
FR3091654B1 (fr) 2019-01-14 2023-05-12 Stiplastics Chambre d’inhalation
US20220218863A1 (en) * 2019-04-25 2022-07-14 Sensory Cloud, Inc. Systems, methods, and articles for delivery of substances in vessels
WO2022047538A1 (en) * 2020-09-03 2022-03-10 Telethon Kids Institute System and method for delivery of a therapeutic agent by inhalation

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2705954A (en) * 1951-10-11 1955-04-12 Goodrich Co B F Respiratory mask and stiffening member therefor
US3923043A (en) * 1973-09-28 1975-12-02 Roman L Yanda Method for acquisition of exhalation tidal volume and minute ventilation data
US4119097A (en) * 1977-02-03 1978-10-10 Applied Research Commodities Industries, Inc. Emergency oxygen supply
US4484577A (en) * 1981-07-23 1984-11-27 Key Pharmaceuticals, Inc. Drug delivery method and inhalation device therefor
GB2137886A (en) * 1983-02-14 1984-10-17 Wb Pharmaceuticals Limited Inhalation bag
GB2182249A (en) * 1986-02-25 1987-05-13 Dr Anand Dhondo Deshpande Compressible nebuhaler
US4790305A (en) * 1986-06-23 1988-12-13 The Johns Hopkins University Medication delivery system
US5020530A (en) * 1990-05-07 1991-06-04 Miller Warren C Inhalation therapy device
WO1993011817A1 (en) * 1991-12-16 1993-06-24 The University Of Melbourne Improvements in the administration of aerosol compounds
JP2606070Y2 (ja) * 1992-05-01 2000-09-11 大塚製薬株式会社 吸入補助具
US5318016A (en) * 1993-03-30 1994-06-07 We Pharmaceuticals, Inc. Inhalation device
GB2285396A (en) 1993-11-22 1995-07-12 Savvas Savoullas Rebreathing bag inhaler
DE4409076C1 (de) * 1994-03-17 1995-05-04 Petra Schleufe Vorrichtung zur Beatmung von Patienten
US5613489A (en) * 1994-12-07 1997-03-25 Westmed, Inc. Patient respiratory system drug applicator
JPH09168592A (ja) * 1995-12-20 1997-06-30 Dr Tool:Kk 医薬吸入器の携帯用アダプター
PL327616A1 (en) * 1996-01-03 1998-12-21 Glaxo Group Ltd Inhaler
US5842467A (en) * 1996-06-19 1998-12-01 Greco; Michael Metered dose inhaler and ambulatory manual breathing unit combination
SE9603063D0 (sv) * 1996-08-23 1996-08-23 Astra Ab Device and method for metering a particulate substance and apparatus comprising a plurality of such devices
DE19851279B4 (de) * 1998-06-17 2006-05-24 GSF - Forschungszentrum für Umwelt und Gesundheit GmbH Vorrichtung zum gesteuerten inhalatorischen Einbringen von dosierten Medikamenten in die Lunge
US6158428A (en) * 1998-12-21 2000-12-12 We Pharmaceuticals Inc. Infant inhaler
US6390090B1 (en) * 1998-12-31 2002-05-21 Samuel David Piper Inhalation therapy apparatus
DE19912265A1 (de) * 1999-03-18 2000-09-21 Gsf Forschungszentrum Umwelt Verfahren und Vorrichtung zur Bereitstellung einer konstanten Medikamenten-Dosis für eine inhalatorische Applikation mit niedrigem Inhalationsfluß
WO2001036032A1 (en) * 1999-11-13 2001-05-25 Chang Yeun Lee Device for aiding administration of asthma drugs
WO2001037910A1 (de) * 1999-11-20 2001-05-31 Michael Hermanussen Vorrichtung zum inhalieren von medikamenten mittels unterstützender druckbeatmung
US6340023B2 (en) * 2000-05-17 2002-01-22 John I. Elkins Rebreather nebulizer device
US6584969B2 (en) * 2000-12-07 2003-07-01 Michael W. Farmer Inhalation therapy assembly and method
EP1351724B1 (en) * 2001-01-12 2005-08-17 Becton, Dickinson and Company Medicament respiratory delivery device, cartridge and method of making same
IL160628A0 (en) * 2001-09-06 2004-07-25 Microdose Technologies Inc Adaptors for inhalers to improve performance
ES2379060T3 (es) * 2001-12-05 2012-04-20 Nupharmx, Llc Dispositivo médico y método para la inhalación de un fármaco aerosolizado con heliox
US7360537B2 (en) 2003-04-16 2008-04-22 Trudell Medical International Antistatic medication delivery apparatus
US20050217667A1 (en) * 2004-03-30 2005-10-06 Sunil Dhuper Aerosol deliver apparatus IV
US7290541B2 (en) * 2004-04-20 2007-11-06 Aerogen, Inc. Aerosol delivery apparatus and method for pressure-assisted breathing systems
US20060260606A1 (en) * 2005-05-18 2006-11-23 Coifman Robert E Inhalable formulations of amphotericin B and methods and devices for delivery thereof
US7726310B2 (en) * 2005-08-24 2010-06-01 Andrus Paul G Medical aerosol non-diluting holding chamber
US7861713B2 (en) * 2006-06-08 2011-01-04 Sunil Kumar Dhuper Adapter for use in an aerosol delivery system
WO2008021451A2 (en) * 2006-08-14 2008-02-21 Aktiv-Dry Llc Human-powered dry powder inhaler and dry powder inhaler compositions
US20080210225A1 (en) * 2007-03-01 2008-09-04 Rapha Institute For Health Disposable antistatic spacer
US7418962B1 (en) * 2007-05-25 2008-09-02 Rao C P Inhaler for aerosol medication
GB0800709D0 (en) * 2008-01-16 2008-02-20 Dunne Stephen T Double jet impinging nozzle
US20110132359A1 (en) 2008-08-12 2011-06-09 Thierry Poree Compactable inhaling device
US8936023B2 (en) * 2009-01-16 2015-01-20 Westmed, Inc. Reservoir system for gas delivery to a patient
US9108011B2 (en) * 2009-04-28 2015-08-18 Boehringer Ingelheim International Gmbh Inhalation device
WO2011125061A2 (en) * 2010-04-07 2011-10-13 Kast Silicone Ltd. Means and method for administering medicaments to infants
EP2747815B1 (en) * 2011-09-07 2017-11-29 Concentrx Pharmaceuticals, Inc. Dry powder inhalation device
US9364622B2 (en) * 2012-04-20 2016-06-14 Fsc Laboratories, Inc. Inhalation devices and systems and methods including the same
GB201221063D0 (en) * 2012-11-23 2013-01-09 3M Innovative Properties Co Metered dose dispensing valve
GB201304784D0 (en) * 2013-03-15 2013-05-01 Euro Celtique Sa Dispenser
CA2945667A1 (en) * 2014-01-31 2015-10-15 The Research Foundation For The State University Of New York Devices and methods for controlled drug delivery of wet aerosols
US20160256641A1 (en) * 2015-03-02 2016-09-08 Edward Lisberg Delivery System for Metered Dose Inhalers

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
ES2884121T3 (es) 2021-12-10
CN109310834B (zh) 2021-07-06
AU2017253951B2 (en) 2021-08-12
AU2017253951A1 (en) 2018-11-01
DK3445428T3 (da) 2021-08-23
JP6979057B2 (ja) 2021-12-08
JP2019511348A (ja) 2019-04-25
US11207476B2 (en) 2021-12-28
WO2017181228A1 (en) 2017-10-26
US20190125991A1 (en) 2019-05-02
CN109310834A (zh) 2019-02-05
PT3445428T (pt) 2021-08-30
EP3445428A1 (en) 2019-02-27
MX2018012581A (es) 2019-06-17
PL3445428T3 (pl) 2021-11-22
CA3021217A1 (en) 2017-10-26
EP3445428A4 (en) 2019-12-18

Similar Documents

Publication Publication Date Title
AU2018255505B2 (en) Dry powder inhaler and spacer device for a dry powder inhaler
EP3445428B1 (en) Spacer device for an inhaler
ES2715630T3 (es) Dispositivos de inhalación y sistemas
JP4578689B2 (ja) エーロゾル薬物供給装置及び方法
JP4350837B2 (ja) 肺への薬の吸入投与のための装置
JP2004530480A (ja) 加圧式ドラッグデリバリーシステムにおける顔面マスク
JPH057018B2 (pl)
AU2018255504B2 (en) Spacer device for a nebuliser
JP2019520925A (ja) 患者の人工呼吸または呼吸補助の際の粉末エアロゾルの呼吸制御への適用
JP2019513436A (ja) 上気道に粒子を投与する装置及び方法
US6701915B1 (en) Device for inhaling medicaments using supported pressure respiration
WO2021207064A1 (en) Valved holding chamber with exhalation filter
US20080190420A1 (en) Aerosol Medication Delivery Apparatus

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20181019

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20191115

RIC1 Information provided on ipc code assigned before grant

Ipc: A61M 15/00 20060101AFI20191111BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20201204

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602017038890

Country of ref document: DE

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1393387

Country of ref document: AT

Kind code of ref document: T

Effective date: 20210615

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: FI

Ref legal event code: FGE

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

Effective date: 20210819

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: PT

Ref legal event code: SC4A

Ref document number: 3445428

Country of ref document: PT

Date of ref document: 20210830

Kind code of ref document: T

Free format text: AVAILABILITY OF NATIONAL TRANSLATION

Effective date: 20210818

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: GR

Ref legal event code: EP

Ref document number: 20210402207

Country of ref document: GR

Effective date: 20210915

REG Reference to a national code

Ref country code: NO

Ref legal event code: T2

Effective date: 20210519

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210519

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210519

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210819

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210919

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210519

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210519

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2884121

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20211210

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210519

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210519

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210519

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210519

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602017038890

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20220222

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210919

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210519

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220418

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PT

Payment date: 20230418

Year of fee payment: 7

Ref country code: NO

Payment date: 20230419

Year of fee payment: 7

Ref country code: IT

Payment date: 20230420

Year of fee payment: 7

Ref country code: FR

Payment date: 20230418

Year of fee payment: 7

Ref country code: ES

Payment date: 20230502

Year of fee payment: 7

Ref country code: DK

Payment date: 20230418

Year of fee payment: 7

Ref country code: DE

Payment date: 20230418

Year of fee payment: 7

Ref country code: CH

Payment date: 20230502

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: TR

Payment date: 20230418

Year of fee payment: 7

Ref country code: SE

Payment date: 20230418

Year of fee payment: 7

Ref country code: PL

Payment date: 20230418

Year of fee payment: 7

Ref country code: AT

Payment date: 20230418

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20230418

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20170418

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GR

Payment date: 20240312

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20240311

Year of fee payment: 8

Ref country code: NL

Payment date: 20240312

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: MC

Payment date: 20240311

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210519

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210519

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FI

Payment date: 20240312

Year of fee payment: 8

Ref country code: CZ

Payment date: 20240321

Year of fee payment: 8

Ref country code: GB

Payment date: 20240303

Year of fee payment: 8